Revised SPC: Sarclisa (isatuximab) 20mg/mL concentrate for solution for infusion

SPC updated with licence extension covering use in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

electronic Medicines compendium